NV
Novo Nordisk
NVO · Novo Nordisk · Healthcare
Up next day
9/16
56%
Fell despite growth
3/16
Good earnings ignored
Avg earnings move
±3.3%
typical swing on earnings
Price when beating
-0.7%
avg over 11 beats
Biggest single move
+7.5%
'24.6 · largest reaction
How this stock reacts to earnings
Traits seen across its recent earnings reactions
Beating estimates doesn't always lift it
Up the next day 6 of 11 beats (55%)
Reaction is erratic and hard to predict
Avg -0.7% on a beat, +1.8% on a miss
vs Healthcare sector avg (153 peers)
This
+0.1%
Sector
+0.4%
Avg next-day reaction
Earnings number vs guidance — which drives it?
How often the beat/miss matched the actual price move
The number and guidance move the price about equally
Moved opposite to results 8 of last 16 times (50%)
5xBeat but fell
Even a beat sells off if guidance disappoints
3xMissed but rose
Even a miss rebounds if guidance reassures
Earnings timeline · tap a bar for that quarter
Nov 4Before open
'26.9 expectedEst. EPS $5.14
Quarter ended 6/2026
Reported 2026-08-04
Next-day move
+0.6%
After 5 days +6.5%
vs Consensus$4.98→$6.18+24.0% beat
EPS
$6.18
YoY +4%
Revenue
—
Next-Q guidance
—
N/A
Price around earnings
Earnings trend · last 12 quarters
EPS$6.18YoY +4%
'23.9'26.6
Revenue—
'23.9'26.6
Price vs earnings · last 16 quarters
↑Up↓Down
Bad news out
weak · up ↑
0x
Met expectations
good · up ↑
7x58%
Disappointment
weak · down ↓
2x17%
Good earnings ignored
good · down ↓
3x25%
← ← Weak earningsStrong earnings → →
Mostly 'honest' — good earnings, price up · 7 of 12q (58%)
Community · NVO
What do you think of this stock's earnings pattern?
···